Beam Therapeutics Inc.

NASDAQ: BEAM · Real-Time Price · USD
17.64
0.12 (0.68%)
At close: Aug 14, 2025, 3:59 PM
17.72
0.45%
Pre-market: Aug 15, 2025, 04:09 AM EDT

Beam Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.42 -15.85 -10.39 -14.99
PEG Ratio
-0.03 0.29 0.36 4.57
PS Ratio
32.14 5.56 44.95 98.73
PB Ratio
2.78 2.14 3.73 6.19
P/FCF Ratio
-5.73 -11.48 -103.63 -45.26
P/OCF Ratio
-5.88 -14.08 121.56 -77.24
OCF/S Ratio
-5.47 -0.39 0.37 -1.28
Debt / Equity Ratio
0.22 0.18 0.24 0.17
Quick Ratio
4.82 5.89 4.89 7.37
Current Ratio
4.82 5.89 4.89 4.52
Asset Turnover
0.06 0.26 0.05 0.04
Interest Coverage
n/a n/a -22.13 -43.61K
Return on Equity
-0.51 -0.14 -0.36 -0.41
Return on Assets
-0.34 -0.09 -0.2 -0.23
Return on Invested Capital
-0.44 -0.14 -0.3 -0.28
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -0.16 0.63 0.68
Net Profit Margin
-5.93 -0.35 -4.33 -6.58
Pretax Profit Margin
-5.93 -0.35 -4.27 -7.15
Operating Profit Margin
-6.54 -0.47 -5.56 -7.57
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-6.05 -0.41 -5.32 -7.57